Hamilton, Waikato, New Zealand Clinical Trials

A listing of Hamilton, Waikato, New Zealand clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
Featured trial
Evaluating the Psychometric Properties of Three Clinical Trial Outcome Measures for Rett Syndrome

Evaluating the Psychometric Properties of Three Clinical Trial Outcome Measures for Rett Syndrome: The purpose of this research study is to document the psychometric properties of three non-invasive, clinic-friendly, and quantifiable outcome measures reflecting pathologically- and clinically-relevant symptoms of Rett Syndrome (RTT). Despite several ongoing or pending clinical trials for …

Online studies
Gillette Children's Hospital
(online study) Contact site
  • 11 views
  • 30 Jun, 2022
  • 1 location
  • Online study
Featured trial
Repetitive Behavior in Early Childhood

The University of Minnesota is seeking family caregivers of children between the ages of 2 and 6 with and without developmental delays to respond to a survey. The purpose of this survey is to learn more about the development of repetitive behavior in early childhood. The survey is fully virtual …

Accepts healthy volunteers
Online studies
University of Minnesota, Department of Psychology
(online study) Contact site
  • 19 views
  • 30 Jun, 2022
  • 1 location
  • Online study
Featured trial
Caregiver-Provided Life Review for Persons with Dementia in Care Facilities

This study, Caregiver-Provided Life Review (C-PLR) is created based on Life Review therapy. It is for persons living with early-stage dementia along with mild depressive symptoms who are 65 years or older, community-dwellers or the residents of senior housing, independent or assisted living facilities conducted by their family members (18 …

dementia
Accepts healthy volunteers
Online studies
depression
Online Study Center
(online study) Contact site
  • 503 views
  • 05 Jul, 2022
  • 1 location
  • Online study
Objective, Passive Assessment of LRRK2 Carriers (OPAL)

This study is currently only open to active participants in the University of Rochester’s VALOR-PD study. The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless …

movement disorder
Online studies
University of Rochester
(online study) Contact site
  • 8 views
  • 12 May, 2022
  • 1 location
  • Online study
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer (EXPERT)

This is a randomised, phase III, non-inferiority trial evaluating radiation therapy versus observation following breast conserving surgery and planned endocrine therapy in patients with stage I breast cancer of luminal A subtype defined using the Prosigna (PAM50) Assay.

Palmerston North Hospital
 (176.3 away) Contact site
  • 733 views
  • 04 May, 2022
  • +55 other locations
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection (MARCH)

This is a phase 2 study in which subjects with chronic hepatitis B virus (HBV) infection will receive VIR-2218, VIR-3434 and/or PEG-IFNα and be assessed for safety, tolerability, and efficacy

Investigative Site
 (46.7 away) Contact site
  • 7 views
  • 03 May, 2022
  • +16 other locations
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD) (PROTECT-ICD)

The PROTECT-ICD trial is a physician-led, multi-centre randomised controlled trial targeting prevention of sudden cardiac death in patients who have poor cardiac function following a myocardial infarct (MI). The trial aims to assess the role of electrophysiology study (EPS) in guiding implantable cardioverter-defibrillator (ICD) implantation, in patients early following MI …

Waikato Hospital
 (1.3 away) Contact site
  • 267 views
  • 15 May, 2022
  • +25 other locations
Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk PAH Patients (HYPERION)

The objective of this study is to evaluate the effects of sotatercept treatment (plus background PAH therapy) versus placebo (plus background PAH therapy) on time to clinical worsening (TTCW) in participants who are newly diagnosed with PAH and are at intermediate or high risk of disease progression.

Waikato District Health Board ( Site 2702)
 (1.3 away) Contact site
  • 0 views
  • 03 Jul, 2022
  • +74 other locations
A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis (ASPEN)

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

NZL002
 (1.3 away) Contact site
  • 98 views
  • 03 Jul, 2022
  • +331 other locations
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035) (VICTOR)

The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fraction (HFrEF), specifically those with symptomatic chronic HFrEF who have not had a recent hospitalization for heart failure or need for outpatient intravenous (IV) diuretics. The primary …

Waikato Hospital-Cardiology Clinical Trials Unit ( Site 2654)
 (1.3 away) Contact site
  • 5 views
  • 05 Jul, 2022
  • +313 other locations